Overview

Trachoma Elimination Follow-up

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

Summary

The WHO has initiated a program to eliminate blinding trachoma by the year 2020, in large part by mass oral azithromycin distributions. It is not clear how frequently or for how long these treatments are necessary. Here we assess the frequency and duration of treatment.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Azithromycin